Everand Logo

Welcome to Everand!

  • STAT

    ‘Skinny repeal’ bill unveiled: What it could mean for you

    A look at what the "skinny" Republican plan could mean for Americans who rely on the health law's marketplaces, for those with Medicaid, and for others.
    by Erin Mershon and Lev Facher Jul 27, 2017 6 minutes
    Senate Majority Leader Mitch McConnell (R-Ky.), flanked by Senate colleagues, speaks to reporters during a news conference Tuesday in Washington.

    WASHINGTON — Senate Republicans, barreling toward a conclusion of their efforts to dismantle Obamacare, on Thursday night unveiled a new piece of legislation they will consider: a so-called “skinny repeal” that takes aim at only a handful of the Affordable Care Act’s least popular provisions.

    The plan revealed by GOP leaders would strip the “repeal” effort to its most basic elements: nixing the mandate that requires Americans to buy insurance or face a penalty, as well as the companion policy that requires employers to offer health insurance to their workers.

    The new plan also includes a provision to eliminate some Planned Parenthood funding and another that repeals the Prevention and Public Health Fund in 2019, not in 2018 as written in previous drafts. The measure includes $422 million in added funding for community health centers, as well as a temporary repeal of a tax on the medical device industry. There is no added money, as had been speculated, to fight the opioid

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A J&J Cough Syrup, A Pfizer And Moderna Patent Suit, And More
    A Johnson & Johnson children’s cough syrup found to contain unsafe levels of a toxic industrial solvent was sold in six African countries.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About BIO’s China Challenge, Zepbound Shortages, And More
    BIO's about-face in its relationship with WuXi AppTec illustrates the difficulty the biotech industry faces in dealing with an issue that is moving fast and forcefully.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks